Power Law company profile

GondolaBio

Biotech & Life Sciences · Palo Alto, United States · Founded 2024 Unicorn

GondolaBio operates in the biotechnology sector, focusing on accelerating scientific and medical breakthroughs. The company serves a diverse range of clients including research institutions, pharmaceutical companies, and healthcare providers. GondolaBio's business model revolves around leveraging cutting-edge research and development to create innovative solutions that address critical medical and scientific challenges. Revenue is primarily generated through partnerships, licensing agreements, and the commercialization of proprietary technologies. The company is staffed by a multidisciplinary team of scientists, researchers, engineers, and business professionals, all dedicated to pushing the boundaries of what's possible in biotech. Keywords: biotechnology, scientific breakthroughs, medical advancements, research institutions, pharmaceutical companies, healthcare providers, R&D, innovation, proprietary technologies, partnerships.

Valuation

$1–2.5B

Latest valuation · 2024

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Total funding● Pre-IPO

$100–500M

Unlock exact value

Investors

7 investors on GondolaBio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

BridgeBio

Aisling Capital

Patient Square Capital

Sequoia

Viking Global Investors

Cormorant Asset Management

Frazier Life Sciences

Global footprint

Where GondolaBio has talent and traffic

Workforce by country

5 countries with
team presence

🇺🇸 United States93.9%

🇨🇳 China1.5%

🇮🇹 Italy1.5%

🇿🇦 South Africa1.5%

🇮🇳 India1.5%

5 countries shown

Talent graph

The shape of GondolaBio's talent

Dealroom maps GondolaBio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

2 team members profilednamed & role-tagged by Dealroom

85 employeestotal headcount

1 executives & foundersidentified by name

DimensionScore

AI Talent

Engineering

Product

Go-to-market

Leadership

Research

Book a demo to unlock GondolaBio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about GondolaBio

An AI-synthesized read of the highest-engagement posts about GondolaBio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GondolaBio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles